title: Screening with monoclonal anti-Fy3 to provide blood for phenotype-matched transfusions for patients with sickle cell disease.
abstract: BACKGROUND
  In the United States, there is a shortage of blood group phenotype-matched red cells (RBCs) for patients with sickle cell disease (SCD). A protocol designed to supply phenotype-matched RBCs for these patients by combining the recruitment of African American blood donors and automated testing of RBCs for these patients for the presumptive Fy(a-b-) phenotype using monoclonal anti-Fy3 was evaluated.
  
  
  METHODS
  African American donors were recruited, to increase the likelihood of phenotype matches in the donor population. Samples of RBCs were tested for the presumptive Fy(a-b-) phenotype by using monoclonal anti-Fy3 and an automated blood typing analyzer. RBCs confirmed to be Fy(a-b-) were retyped for selected Rh, MNS, Kell, Duffy, and Kidd blood system antigens. The extended phenotypes were matched with those of 41 SCD patients requiring transfusions.
  
  
  RESULTS
  Of 8323 blood donations during the study, approximately 40 percent (3329) were made by African Americans. Approximately 22 percent (737) of African Americans were identified as Fy(a-b-) by this protocol and 12 percent (410) were phenotype matches for the 41 SCD patients.
  
  
  CONCLUSIONS
  Combining the recruitment of African American blood donors and automated phenotyping using monoclonal anti-Fy3 offers a practical, relatively low-cost strategy for supplying phenotype-matched RBCs for SCD patients. This protocol increases the options for addressing the shortage of phenotype-matched RBCs for SCD patients.
authors.affiliation: National Reference Laboratory for Blood Group Serology, American Red Cross, Philadelphia, Pennsylvania, USA.
authors.forename: S G
authors.initials: SG
authors.lastname: Sandler
authors.forename: D
authors.initials: D
authors.lastname: Mallory
authors.forename: J S
authors.initials: JS
authors.lastname: Wolfe
authors.forename: P
authors.initials: P
authors.lastname: Byrne
authors.forename: D M
authors.initials: DM
authors.lastname: Lucas
mesh_terms: D000755:Anemia, Sickle Cell / Q000628:therapy*; D000911:Antibodies, Monoclonal / Q000097:blood*; D044383:Black People / Q000235:genetics; D001788:Blood Grouping and Crossmatching; D001803:Blood Transfusion; D004375:Duffy Blood-Group System / Q000276:immunology*; D004912:Erythrocytes / Q000276:immunology; D005820:Genetic Testing; D006801:Humans; D007518:Isoantibodies / Q000097:blood / Q000235:genetics / Q000276:immunology; D010641:Phenotype; D001741:Black or African American
chemical_list: D000911:Antibodies, Monoclonal; D004375:Duffy Blood-Group System; D007518:Isoantibodies; C061962:anti-Fy(a) antibody